Alpine Global Management LLC acquired a new position in shares of Surmodics, Inc. (NASDAQ:SRDX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 50,000 shares of the company's stock, valued at approximately $1,980,000. Alpine Global Management LLC owned 0.35% of Surmodics at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Modus Advisors LLC acquired a new position in Surmodics during the 4th quarter worth $40,000. R Squared Ltd bought a new stake in Surmodics during the fourth quarter worth approximately $55,000. Legal & General Group Plc boosted its stake in Surmodics by 34.2% during the 4th quarter. Legal & General Group Plc now owns 3,452 shares of the company's stock valued at $137,000 after purchasing an additional 880 shares in the last quarter. Polymer Capital Management US LLC acquired a new position in shares of Surmodics during the 4th quarter valued at $255,000. Finally, SG Americas Securities LLC grew its holdings in Surmodics by 22.1% during the fourth quarter. SG Americas Securities LLC now owns 6,940 shares of the company's stock worth $275,000 after acquiring an additional 1,255 shares during the period. 96.63% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the company. Needham & Company LLC reiterated a "hold" rating on shares of Surmodics in a research report on Thursday, January 30th. Lake Street Capital raised Surmodics from a "hold" rating to a "buy" rating and set a $43.00 price target on the stock in a research report on Friday, March 7th. Finally, StockNews.com assumed coverage on shares of Surmodics in a research report on Monday, February 3rd. They issued a "hold" rating for the company. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $50.00.
Check Out Our Latest Stock Report on Surmodics
Surmodics Stock Up 0.2 %
NASDAQ SRDX traded up $0.06 during trading on Friday, hitting $29.46. 50,560 shares of the company traded hands, compared to its average volume of 278,221. The company has a current ratio of 5.45, a quick ratio of 4.29 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $421.16 million, a P/E ratio of -29.17 and a beta of 1.30. The business has a fifty day simple moving average of $30.00 and a 200 day simple moving average of $35.24. Surmodics, Inc. has a 12 month low of $25.17 and a 12 month high of $42.44.
Surmodics (NASDAQ:SRDX - Get Free Report) last issued its quarterly earnings results on Thursday, February 6th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.04. Surmodics had a negative return on equity of 4.39% and a negative net margin of 11.48%. As a group, sell-side analysts predict that Surmodics, Inc. will post 0.2 EPS for the current year.
About Surmodics
(
Free Report)
Surmodics, Inc, together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD).
Recommended Stories
Before you consider Surmodics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surmodics wasn't on the list.
While Surmodics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
